| Key Financial Ratios of Glenmark Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
27.50 |
32.78 |
28.49 |
39.29 |
26.47 |
|
| Diluted EPS (Rs.) |
27.50 |
32.78 |
28.49 |
39.28 |
26.46 |
|
| Cash EPS (Rs.) |
42.28 |
44.33 |
39.19 |
48.66 |
34.64 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
215.12 |
198.63 |
182.98 |
159.20 |
128.63 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
215.12 |
198.63 |
182.98 |
159.20 |
128.63 |
|
| Revenue from Operations/Share (Rs.) |
377.11 |
349.63 |
321.59 |
321.77 |
267.99 |
|
| PBDIT/Share (Rs.) |
65.84 |
63.58 |
60.49 |
73.50 |
51.64 |
|
| PBIT/Share (Rs.) |
51.05 |
52.03 |
49.79 |
64.13 |
43.34 |
|
| PBT/Share (Rs.) |
38.84 |
46.09 |
39.67 |
52.86 |
37.00 |
|
| Net Profit/Share (Rs.) |
27.50 |
32.78 |
28.49 |
39.29 |
26.33 |
|
| NP After MI And SOA / Share (Rs.) |
27.50 |
32.78 |
28.49 |
39.29 |
26.33 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
17.45 |
18.18 |
18.80 |
22.84 |
19.27 |
|
| PBIT Margin (%) |
13.53 |
14.88 |
15.48 |
19.93 |
16.17 |
|
| PBT Margin (%) |
10.30 |
13.18 |
12.33 |
16.42 |
13.80 |
|
| Net Profit Margin (%) |
7.29 |
9.37 |
8.85 |
12.21 |
9.82 |
|
| NP After MI And SOA Margin (%) |
7.29 |
9.37 |
8.85 |
12.21 |
9.82 |
|
| Return on Networth/Equity (%) |
12.78 |
16.50 |
15.56 |
24.67 |
20.47 |
|
| Return on Capital Employed (%) |
13.64 |
15.82 |
15.09 |
19.97 |
11.99 |
|
| Return on Assets (%) |
5.28 |
6.95 |
6.38 |
9.42 |
7.28 |
|
| Total Debt/Equity (X) |
0.74 |
0.69 |
0.86 |
1.05 |
0.90 |
|
| Asset Turnover Ratio (%) |
72.46 |
74.20 |
72.04 |
77.18 |
74.18 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.65 |
1.67 |
2.13 |
2.54 |
1.48 |
|
| Quick Ratio (X) |
1.13 |
1.11 |
1.51 |
1.75 |
1.08 |
|
| Inventory Turnover Ratio (X) |
4.98 |
4.38 |
4.47 |
4.24 |
4.82 |
|
| Dividend Payout Ratio (NP) (%) |
8.76 |
7.35 |
8.44 |
6.12 |
9.14 |
|
| Dividend Payout Ratio (CP) (%) |
5.70 |
5.43 |
6.14 |
4.94 |
6.94 |
|
| Earnings Retention Ratio (%) |
91.24 |
92.65 |
91.56 |
93.88 |
90.86 |
|
| Cash Earnings Retention Ratio (%) |
94.30 |
94.57 |
93.86 |
95.06 |
93.06 |
|
| Coverage Ratios |
|
|
|
|
|
|
| Interest Coverage Ratios (%) |
3.82 |
4.39 |
4.92 |
7.63 |
6.84 |
|
| Interest Coverage Ratios (Post Tax) (%) |
3.82 |
4.39 |
4.92 |
7.63 |
6.84 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
9,188.07 |
21,154.12 |
18,076.35 |
27,868.58 |
24,829.26 |
|
| EV/Net Operating Revenue (X) |
0.86 |
2.14 |
1.99 |
3.07 |
3.28 |
|
| EV/EBITDA (X) |
4.95 |
11.79 |
10.59 |
13.44 |
17.04 |
|
| MarketCap/Net Operating Revenue (X) |
0.55 |
1.85 |
1.64 |
2.67 |
2.96 |
|
| Retention Ratios (%) |
91.23 |
92.64 |
91.55 |
93.87 |
90.85 |
|
| Price/BV (X) |
0.96 |
3.25 |
2.88 |
5.39 |
6.17 |
|
| Price/Net Operating Revenue |
0.55 |
1.85 |
1.64 |
2.67 |
2.96 |
|
| Earnings Yield |
0.13 |
0.05 |
0.05 |
0.05 |
0.03 |
|
Source : Dion Global Solutions Limited
